Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027
Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7. 9 Billion by 2027. - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.
New York, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Neglected Tropical Diseases Diagnosis Industry" - https://www.reportlinker.com/p06032319/?utm_source=GNW
9 Billion by 2027, growing at aCAGR of 4% over the period 2020-2027. Conventional, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$4.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Molecular / Modern segment is readjusted to a revised 4.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 6.4% CAGR
- The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.
- Select Competitors (Total 33 Featured) -
Abbott Laboratories
Beckman Coulter/Danaher
Bio-Rad Laboratories, Inc.
Coris Bioconcept SPRL
DiaSys Diagnostic Systems GmbH
F. Hoffmann-La Roche Ltd.
Genome Diagnostics Pvt. Ltd
InBios International, Inc.
Life Technology
Novartis Diagnostics., Ltd.
Omega Diagnostics Group PLC
Ortho-Clinical Diagnostics
Oscar Medicare Pvt Ltd.
Premier Medical Corporation Ltd.
Siemens Healthcare
Thermo Fisher Scientific, Inc.
Wako Chemicals, Inc.
ZeptoMetrix
Read the full report: https://www.reportlinker.com/p06032319/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Neglected Tropical Diseases
Diagnosis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Conventional by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Conventional by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 6: World 15-Year Perspective for Conventional by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Molecular / Modern
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Molecular / Modern by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Molecular / Modern by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Centralized by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for Centralized by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 12: World 15-Year Perspective for Centralized by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Point of Care by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 14: World Historic Review for Point of Care by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 15: World 15-Year Perspective for Point of Care by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Clinical Labs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for Clinical Labs by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 18: World 15-Year Perspective for Clinical Labs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Home Healthcare
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 23: World Historic Review for Home Healthcare by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Home Healthcare by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 25: USA Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 26: USA Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 27: USA 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 28: USA Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR
Table 29: USA Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 30: USA 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 31: USA Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 32: USA Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 33: USA 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
CANADA
Table 34: Canada Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 35: Canada Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 36: Canada 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 37: Canada Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 38: Canada Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 39: Canada 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 40: Canada Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR
Table 41: Canada Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 42: Canada 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
JAPAN
Table 43: Japan Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 44: Japan Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 45: Japan 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 46: Japan Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 47: Japan Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 48: Japan 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 49: Japan Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR
Table 50: Japan Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 51: Japan 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
CHINA
Table 52: China Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 53: China Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 54: China 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 55: China Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 56: China Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 57: China 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 58: China Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR
Table 59: China Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 60: China 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
EUROPE
Table 61: Europe Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR
Table 62: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR
Table 63: Europe 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2012, 2020 & 2027
Table 64: Europe Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 65: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 66: Europe 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 67: Europe Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 68: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 69: Europe 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 70: Europe Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR
Table 71: Europe Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 72: Europe 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
FRANCE
Table 73: France Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 74: France Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 75: France 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 76: France Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 77: France Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 78: France 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 79: France Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR
Table 80: France Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 81: France 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
GERMANY
Table 82: Germany Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 83: Germany Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 84: Germany 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 85: Germany Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 86: Germany Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 87: Germany 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 88: Germany Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR
Table 89: Germany Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 90: Germany 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
ITALY
Table 91: Italy Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 92: Italy Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 93: Italy 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 94: Italy Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 95: Italy Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 96: Italy 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 97: Italy Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR
Table 98: Italy Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 99: Italy 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 100: UK Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR
Table 101: UK Historic Review for Neglected Tropical Diseases
Diagnosis by Method - Conventional and Molecular / Modern
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 102: UK 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 103: UK Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR
Table 104: UK Historic Review for Neglected Tropical Diseases
Diagnosis by Service Type - Centralized and Point of Care
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR
Table 105: UK 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 106: UK Current & Future Analysis for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 107: UK Historic Review for Neglected Tropical Diseases
Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and
Home Healthcare Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 108: UK 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
SPAIN
Table 109: Spain Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 110: Spain Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 111: Spain 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 112: Spain Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 113: Spain Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 114: Spain 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 115: Spain Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR
Table 116: Spain Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 117: Spain 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
RUSSIA
Table 118: Russia Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR
Table 119: Russia Historic Review for Neglected Tropical
Diseases Diagnosis by Method - Conventional and Molecular /
Modern Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 120: Russia 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Method - Percentage Breakdown of Value
Sales for Conventional and Molecular / Modern for the Years
2012, 2020 & 2027
Table 121: Russia Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR
Table 122: Russia Historic Review for Neglected Tropical
Diseases Diagnosis by Service Type - Centralized and Point of
Care Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 123: Russia 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by Service Type - Percentage Breakdown of
Value Sales for Centralized and Point of Care for the Years
2012, 2020 & 2027
Table 124: Russia Current & Future Analysis for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR
Table 125: Russia Historic Review for Neglected Tropical
Diseases Diagnosis by End-Use - Clinical Labs, Hospitals &
Clinics and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 126: Russia 15-Year Perspective for Neglected Tropical
Diseases Diagnosis by End-Use - Percentage Breakdown of Value
Sales for Clinical Labs, Hospitals & Clinics and Home
Healthcare for the Years 2012, 2020 & 2027
REST OF EUROPE
Table 127: Rest of Europe Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Method - Conventional
and Molecular / Modern - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR
Table 128: Rest of Europe Historic Review for Neglected
Tropical Diseases Diagnosis by Method - Conventional and
Molecular / Modern Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR
Table 129: Rest of Europe 15-Year Perspective for Neglected
Tropical Diseases Diagnosis by Method - Percentage Breakdown of
Value Sales for Conventional and Molecular / Modern for the
Years 2012, 2020 & 2027
Table 130: Rest of Europe Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by Service Type -
Centralized and Point of Care - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 131: Rest of Europe Historic Review for Neglected
Tropical Diseases Diagnosis by Service Type - Centralized and
Point of Care Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR
Table 132: Rest of Europe 15-Year Perspective for Neglected
Tropical Diseases Diagnosis by Service Type - Percentage
Breakdown of Value Sales for Centralized and Point of Care for
the Years 2012, 2020 & 2027
Table 133: Rest of Europe Current & Future Analysis for
Neglected Tropical Diseases Diagnosis by End-Use - Clinical
Labs, Hospitals & Clinics and Home Healthcare - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR
Table 134: Rest of Europe Historic Review for Neglected
Tropical Diseases Diagnosis by End-Use - Clinical Labs,
Hospitals & Clinics and Home Healthcare Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR
Table 135: Rest of Europe 15-Year Perspective for Neglected
Tropical Diseases Diagnosis by End-Use - Percentage Breakdown
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032319/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001